drugset / Trial / NCT04586803

Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers

NCT04586803

Phase 1 Unknown 24 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedSequentialOpen-labelBasic science

Summary

The primary objective of the study is to evaluate the relative bioavailability of three different prescription processes of SHR4640 tablets in healthy volunteers. The secondary objective of the study is to observe the safety of SHR4640 tablets in healthy subjects.

Timeline

Start
2020-10
Primary completion
2020-11
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR4640 Small molecule

Indications